PP
PDT Partners’s Pacific Biosciences PACB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-19,711
| Closed | -$511K | – | 854 |
|
|
2020
Q4 | $511K | Buy |
+19,711
| New | +$511K | 0.03% | 448 |
|
|
2020
Q3 | – | Sell |
-17,696
| Closed | -$61K | – | 826 |
|
|
2020
Q2 | $61K | Buy |
+17,696
| New | +$61K | ﹤0.01% | 644 |
|
|
2018
Q4 | – | Sell |
-286,310
| Closed | -$1.55M | – | 503 |
|
|
2018
Q3 | $1.55M | Buy |
286,310
+118,510
| +71% | +$641K | 0.06% | 269 |
|
|
2018
Q2 | $596K | Hold |
167,800
| – | – | 0.02% | 381 |
|
|
2018
Q1 | $344K | Sell |
167,800
-89,400
| -35% | -$183K | 0.01% | 482 |
|
|
2017
Q4 | $679K | Sell |
257,200
-137,600
| -35% | -$363K | 0.02% | 395 |
|
|
2017
Q3 | $2.07M | Hold |
394,800
| – | – | 0.07% | 272 |
|
|
2017
Q2 | $1.41M | Buy |
394,800
+146,423
| +59% | +$521K | 0.06% | 297 |
|
|
2017
Q1 | $1.28M | Buy |
+248,377
| New | +$1.28M | 0.07% | 289 |
|